Strategia Information

STRATEGIA is a Basel-based strategic marketing consultancy, specialized in providing commercial support for products in early development (from late pre-clinical stages through to the end of phase 2). We support our clients in developing a better understanding the commercial opportunities and risks associated with: - their pipeline assets, and - assets which they are evaluating for in- or out-licensing. Our mission is to ensure that our clients optimize the value of their pipeline assets, and maximize returns for their investors. To deliver on our mission, we have developed an approach called “Differentiation by Design”, which encompasses: - Understanding market dynamics - Selection of the optimal launch indication - Patient segmentation - Competitor benchmarking - Positioning based on customer insights - Development of a differentiated TPP, including claims required to demonstrate value to payers. - Clinical development strategy. STRATEGIA operates as a network of experts with global experience in their fields, in biopharma and/or consulting companies. Our motto: “The molecule is what it is, but how you develop it matters!”